The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma

✍ Scribed by Kent, S. E.; Boyce, M.; Diamant, Z.; Singh, D.; O'Connor, B. J.; Saggu, P. S.; Norris, V.

• Book ID: 119827270
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 337 KB
• Volume: 43
• Category: Article
• ISSN: 0954-7894
• DOI: 10.1111/cea.12002